Phibro Animal Health Corp. (PAHC): Price and Financial Metrics

PAHC POWR Grades

• Value is the dimension where PAHC ranks best; there it ranks ahead of 96.82% of US stocks.
• PAHC's strongest trending metric is Stability; it's been moving down over the last 178 days.
• PAHC's current lowest rank is in the Momentum metric (where it is better than 8.94% of US stocks).

PAHC Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for PAHC is 3.65 -- better than 86.24% of US stocks.
• Of note is the ratio of PHIBRO ANIMAL HEALTH CORP's sales and general administrative expense to its total operating expenses; 86.85% of US stocks have a lower such ratio.
• PAHC's price/sales ratio is 0.53; that's higher than the P/S ratio of merely 17.23% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to PHIBRO ANIMAL HEALTH CORP are TGLS, BDL, BVH, RCKY, and LIVE.
• PAHC's SEC filings can be seen here. And to visit PHIBRO ANIMAL HEALTH CORP's official web site, go to www.pahc.com.

PAHC Valuation Summary

• PAHC's price/earnings ratio is 10.8; this is 53.85% lower than that of the median Healthcare stock.
• PAHC's price/earnings ratio has moved down 15 over the prior 105 months.

Below are key valuation metrics over time for PAHC.

PAHC Growth Metrics

Its 3 year net income to common stockholders growth rate is now at -13.55%.
• Its year over year revenue growth rate is now at 13.56%.
• The 2 year price growth rate now stands at -12.54%.

Over the past 15 months, PAHC's revenue has gone up $126,767,000.

The table below shows PAHC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	960.117	17.13	46.497
2022-06-30	942.261	31.649	49.175
2022-03-31	907.274	33.145	58.809
2021-12-31	879.384	43.638	53.281
2021-09-30	852.821	50.429	48.617
2021-06-30	833.35	48.306	54.385

PAHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PAHC has a Quality Grade of C, ranking ahead of 53.34% of graded US stocks.
• PAHC's asset turnover comes in at 1.029 -- ranking 22nd of 681 Pharmaceutical Products stocks.
• CLVS, ELTP, and AZN are the stocks whose asset turnover ratios are most correlated with PAHC.

The table below shows PAHC's key quality metrics over time.